CervoMed Inc. Common Stock, Value, Issued
CervoMed Inc. (CRVO) had Common Stock, Value, Issued of $13.53 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Issued $13.53K.
- 2026-03-31: Common Stock, Value, Issued $9.26K.
- 2025-12-31: Common Stock, Value, Issued $9.25K.
- 2025-09-30: Common Stock, Value, Issued $9.25K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $13.53K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $9.26K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $9.25K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $9.25K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $9.25K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $8.70K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $8.70K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $8.25K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $8.25K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $6.17K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $5.67K 10-K · filed 2025-03-17 | |
| 2023-09-30 | $5.67K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.04K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.04K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $518.00 10-K · filed 2024-03-29 | $2.04K 10-K · filed 2023-03-24 |
| 2022-09-30 | $2.04K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.04K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.04K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.04K 10-K · filed 2023-03-24 | $101.91K 10-K · filed 2022-03-18 |
| 2021-09-30 | $101.90K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $101.90K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $101.90K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $64.02K 10-K · filed 2022-03-18 | |
| 2020-09-30 | $64.02K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $64.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $34.60K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $33.48K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $4.69K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $4.69K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $3.38K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.38K 10-K · filed 2020-03-17 | |
| 2018-09-30 | $50.57K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $50.57K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $50.53K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $968.00 10-K · filed 2019-03-19 | $14.52K 10-K · filed 2018-04-02 |
| 2017-09-30 | $14.50K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $12.30K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $10.35K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $10.35K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $10.35K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $103.45K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $102.43K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $8.12K 10-K · filed 2017-03-31 | $18.61K 10-K · filed 2016-03-25 |
| 2015-09-30 | $18.61K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $18.61K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $18.61K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $18.61K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $18.51K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $18.39K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $8.68K 10-Q · filed 2014-05-20 | |
| 2013-12-31 | $5.81K 10-K · filed 2015-04-03 | |
| 2013-09-30 | $420.97K 10-Q · filed 2013-11-19 | |
| 2013-06-30 | $400.23K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $90.47K 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $891.00 10-K/A · filed 2014-04-23 | $89.08K 10-K/A · filed 2013-04-24 |
| 2012-09-30 | $90.31K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $89.23K 10-Q/A · filed 2012-09-07 | |
| 2011-12-31 | $88.16K 10-K/A · filed 2013-04-24 | |
| 2011-09-30 | $77.86K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $75.56K 10-Q · filed 2011-08-16 | |
| 2010-12-31 | $64.12K 10-Q · filed 2011-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |